Bespoke Extracts Inc
OTC:BSPK
Relative Value
The Relative Value of one
BSPK
stock under the Base Case scenario is
0.2607
USD.
Compared to the current market price of 0.2524 USD,
Bespoke Extracts Inc
is
Undervalued by 3%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
BSPK Competitors Multiples
Bespoke Extracts Inc Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Bespoke Extracts Inc
OTC:BSPK
|
2.8m USD | 2.3 | -3 | -4.9 | -5 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
986.9B USD | 15.1 | 47.8 | 32.2 | 34.4 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
596.5B USD | 6.3 | 22.3 | 15.4 | 19 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
283.9B CHF | 4.6 | 30.2 | 12.8 | 14.9 | |
| CH |
|
Novartis AG
SIX:NOVN
|
247.6B CHF | 5.7 | 22.9 | 14.1 | 18.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
238.1B GBP | 5.5 | 31.3 | 17.3 | 24.4 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
305.9B USD | 4.7 | 16.8 | 10.4 | 12.6 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 344.9 | 865 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.4 | 10.2 | 7.6 | 8.9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
156.9B USD | 2.5 | 20.2 | 7.7 | 10.3 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
125.6B USD | 2.6 | 17.8 | 7.4 | 9.2 |